Physician profile
Michael L Krychman
NPI 1982689725
$546,945.09
in general payments reported to CMS, 2019-2025
16 companies · $46K in 2025
The $46K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226K · 2020: $43K · 2021: $53K · 2022: $65K · 2023: $67K · 2024: $47K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $146K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $1,246 · Travel and Lodging: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $145,761.74 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,390.00 |
| Food and Beverage | $1,245.99 |
| Travel and Lodging | $254.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $389,123.30 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $86,008.92 | 2019-2021 | |
| Scynexis, INC. | $18,449.59 | 2022 | |
| Lupin INC. | $15,917.69 | 2019 | |
| Astellas Pharma US INC | $14,187.86 | 2023 | Veozah |
| Coopersurgical, INC. | $7,510.72 | 2019 | |
| Amag Pharmaceuticals, INC. | $6,121.70 | 2019 | |
| Duchesnay USA Incorporated | $4,354.35 | 2019 | |
| Evofem Biosciences, INC. | $3,100.04 | 2021 | |
| Ferring Pharmaceuticals INC. | $1,824.00 | 2019 | |
| Sumitomo Pharma America, INC. | $98.78 | 2023 | Myfembree |
| Glaxosmithkline, LLC. | $73.92 | 2023 | Brexafemme |
| Pfizer INC. | $64.89 | 2022-2024 | |
| Hologic Sales and Service, LLC | $45.77 | 2024 | Omni Hysteroscope |
| Allergan, INC. | $39.95 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $23.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Krychman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.